Trump to announce Lilly, Novo drug pricing deals; FDA approved a pricey drug over reviewer concerns; Novo’s new obesity pill.

Dow Jones Top Company Headlines at 3 AM ET: Pfizer Preps Improved Offer in Metsera Bidding War | OpenAI ... Pfizer is preparing to sweeten its offer again for Metsera, the weight-loss drug startup at ...

The dramatic bidding war kicked off last week with Novo's surprise play for Metsera, which had already agreed to be acquired ...

Pfizer plans to sweeten its bid for Metsera , a person familiar with the matter told Reuters, after a judge denied its ...

A judge denied Pfizer Inc.’s request to temporarily block Novo Nordisk A/S’ $10 billion bid to acquire the obesity startup ...

Pfizer is preparing to sweeten its offer again for Metsera, the weight-loss drug startup at the center of a bidding war that ...

Novo Nordisk's $10 billion bid for Metsera, an obesity drug developer, is embroiled in legal scrutiny over potential U.S. antitrust law violations. As Pfizer and Novo vie for Metsera, the FTC warns of ...

WILMINGTON, Delaware (Reuters) -A Delaware judge said on Wednesday she would reject a request by Pfizer to temporarily block ...

Amid the rapidly unfolding saga revolving around Metsera, a judge has denied Pfizer’s request to block Novo Nordisk’s buyout ...

The Federal Trade Commission has raised concerns about Novo Nordisk’s attempt to outbid Pfizer to acquire obesity startup ...

A judge denied Pfizer's ( PFE) request to temporarily block Novo Nordisk's ( NVO) $10 billion bid for Metsera. Metsera rose 2 ...

As Novo Nordisk and Pfizer vie for control of Metsera, a new round of takeout proposals has resulted in the obesity biotech ...